PRICE T ROWE ASSOCIATES INC /MD/ - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$53
-30.3%
12,155
+6.4%
0.00%
Q2 2023$76
+7.0%
11,429
+10.1%
0.00%
Q1 2023$71
-100.0%
10,380
-97.2%
0.00%
-100.0%
Q1 2015$3,400,000
-94.8%
365,628
-92.0%
0.00%
-92.9%
Q4 2014$65,517,000
+53.8%
4,575,221
+11.5%
0.01%
+55.6%
Q3 2014$42,605,000
-23.2%
4,104,521
+19.8%
0.01%
-25.0%
Q2 2014$55,445,000
+94.8%
3,426,791
+95.6%
0.01%
+100.0%
Q1 2014$28,468,000
-5.1%
1,751,881
-27.5%
0.01%
+100.0%
Q4 2013$29,992,000
+11661.6%
2,416,802
+10317.2%
0.00%
Q3 2013$255,000
-44.3%
23,200
-59.0%
0.00%
Q2 2013$458,00056,6000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders